Welcome to the Antimicrobial Chemotherapy Virtual Conference 2022

This conference is free of charge to attend.

Register here

This virtual conference is jointly organised by GARDP and the BSAC. For 2022, we are collaborating with the Center For Disease Dynamics, Economics & Policy (CDDEP) and the Indian Council of Medical Research (ICMR).

This conference is RCPath CPD accredited.

 

Programme

If you are unsure on timings or if the timezones are not applicable you can visit here to work out specific timings for your location.

Select to see different time zones. Default is GMT.

1030
1130
1600
Introductory remarks
Professor Laura JV Piddock, Scientific Director, GARDP - View Bio

SESSION ONE: KEYNOTE PRESENTATION
Chair: Dr Manica Balasegaram, Executive Director, GARDP - View Bio
1035
1135
1605
Regulatory challenges and global access to new antibiotics
Professor Ramanan Laxminarayan, Director, CDDEP
1055
1155
1625
Q&A

1105
1205
1635
BREAK

SESSION TWO: Early drug discovery: new targets and new chemistry
Chair: Dr Adam Roberts, Liverpool School of Tropical Medicine, UK
1115
1215
1645
Dual fluorescent timer module for screening of anti-persister agents
Ranjana Pathania, PhD Professor, Department of Biotechnology Indian Institute of Technology, Roorkee Uttarakhand, India
1130
1230
1700
Discovery and optimization of β-sliding clamp (DnaN) inhibitors
Dr Anna Hirsch, Helmholtz Centre for Infection Research
1145
1245
1715
New ways to identify novel antibacterial chemical entities - Identification of Novel Antibacterials Using Machine Learning Techniques
Mr Ed Siegwart, Oppilotech Ltd
1200
1300
1730
Q&A

1210
1310
1740
BREAK

SESSION THREE: Preclinical antimicrobial development
Chair: Dr Taslimarif Sayyed, CEO CAMP
1220
1320
1750
WHO Priority pathogen list and WHO preclinical pipeline analysis
Valeria Gigante, World Health Organization
1235
1335
1805
Preclinical studies including independent evaluation of new products: Wockhardt’s novel Gram negative antibiotic - cefepime/zidebactam
Dr Sachin Bhagwat, Vice-president of R&D, Wockhardt
1250
1350
1820
Overview of CARB-X pipeline
Dr Erin Duffy, Chief of Research & Development, CARB-X
1305
1405
1835
Q&A

1315
1415
1845
BREAK

SESSION FOUR: Panel Discussion
Chair: Dr Sujith Chandy, Professor, Department of Pharmacology & Clinical Pharmacology at Christian Medical College, India
1325
1425
1855
Evidence for the use of old and new antibiotics
Panellists: Dr Susan Hopkins (UKHSA), Dr Priscilla Rupali (Prof Infectious Diseases, Christian Medical College, Vellore), Professor Herman Goossens (Professor of Microbiology, University of Antwerp), Subasree Srinivasan (Medical Director, GARDP)
Dr Susan Hopkins - View Bio

1420
1520
1950
Closing remarks
Dr Christopher Longshaw, EU Scientific Advisor, Shionogi & BSAC Honorary Treasurer
1030
1130
1600
Introductory remarks
Dr Christopher Longshaw, EU Scientific Advisor, Shionogi & BSAC Honorary Treasurer

SESSION FIVE: Clinical development
Chair: Dr Anil Koul, Johnson and Johnson
1035
1135
1605
Overview of clinical pipeline for antimicrobials - will it meet the future unmet need?
Professor Mical Paul, Infectious Diseases Clinician, Institute at Rambam Health Care Campus & Professor, Faculty of Medicine, Technion (Israel Institute of Technology)
1050
1150
1620
Emerging antibiotic market in the Indian subcontinent
Dr Pankaj Gupta, Chief Scientific Officer, Novartis India, Mumbai
1105
1205
1635
Clinical development of non-traditional antibiotics
Balganesh Gangagen
1120
1220
1650
Q&A

1130
1230
1700
BREAK

SESSION SIX: Oral Poster Presentations
Chair: Dr Geetanjali Kapoor, Research Fellow, Center for Disease Dynamics, Economics & Policy
1140
1240
1710
5 x 5 minute pre-recorded oral poster presentations
1205
1305
1735
Q&A

1215
1315
1745
BREAK

SESSION SEVEN: Impact of the COVID-19 pandemic on infections and antimicrobial resistance
Chair: Dr Ramsubramanian, Apollo Chennai
1225
1325
1755
Impact of Covid 19 on Antimicrobial stewardship
Dr Andrew Seaton, Consultant in Infectious Diseases and General Medicine, NHS Greater Glasgow and Clyde - View Bio
1240
1340
1810
How has Indian AMR data changed post-Covid
Dr Kamini Walia, Program officer AMR Division of Epidemiology and Communicable Diseases, Indian Council of Medical Research
1255
1355
1825
Impact of Covid-19 on treatment of fungal infections
Dr Arunaloke Chakrabarti, PGIMER, Chandigarh
1310
1410
1840
Q&A

1320
1420
1850
BREAK

SESSION EIGHT: Panel Discussion
Chair: Professor Philip Howard OBE, Consultant Antimicrobial Pharmacist, Leeds Teaching Hospitals and University of Leeds - View Bio
1330
1430
1900
More than one way to do it – R&D of new antimicrobials: incentives and models
Panellists: Anand Anandkumar, Dr Manica Balasegaram (GARDP), Jenny Hellman

1425
1525
1955
Closing remarks
Professor Laura JV Piddock, Scientific Director, GARDP - View Bio

Abstracts

Please submit your abstract(s) using the online submission form for consideration for ORAL and/or POSTER presentation at the conference.

Abstracts selected for oral presentation will be invited to present as part of Session Six on Day Two of the conference.

The deadline for ORAL abstract submission is 1200hrs GMT on Friday 10 December 2021.
The deadline for POSTER abstract submission is 1200hrs GMT on Friday 10 December 2021.

Please note our Conditions of Submission:

  1. Abstracts must be submitted by the stated deadline, abstracts submitted after this time will not be considered.
  2. The first author should ideally be the presenting author. All correspondence will be sent to the lead author.
  3. The presenting author must register for the conference.
  4. Those submitting abstracts for ORAL presentation are also requested to submit a short video with a 2-minute elevator pitch of their presentation for the committee to review and make their final selection.  Selected authors will be requested to pre-record their final presentation and to join Session Six to take part in the live Q&A discussion at the end of the session. Guidelines to oral presentations.
  5. If selected for POSTER presentation authors are required to submit their poster in pdf format two weeks prior to the conference.
  6. All abstracts need to be submitted using the online submission form.

Deadlines for ORAL submissions:

  • Abstract submission deadline: 1200hrs GMT on Friday 10 December 2021.
  • Authors notified of final selection decision: Thursday 23 December 2021
  • Author submission of final video: 1200hrs GMT on Wednesday 19 January 2022 (Files received after this time or not adhering to the stated requirements may not be included).

Deadlines for POSTER submissions:

  • Abstract submission deadline: 1200hrs GMT on Friday 10 December 2021
  • Authors notified of selection decision: Thursday 23 December 2021
  • Author submission of final PDF poster: 1200hrs GMT on Wednesday 19 January 2022 (Files received after this time may not be included).

Format of Abstracts:
Structured Abstract (maximum word count 400 excluding graphs & tables):

  • an initial statement of specific objectives of the study, unless this is given in the title;
  • a brief statement of methods;
  • a summary of the results obtained;
  • specific conclusions.

For any queries regarding abstract submissions, please contact Esme Carruthers.

    Lead Author Name
    Lead Author Contact Email
    Role and Organisation
    Presentation Preference (please select)
    Abstract Title
    Author Names and Organisations
    Structured Abstract (maximum word count 400 excluding graphs & tables)
    Supporting document

    Registration

    Please register to attend this virtual conference free of charge using the link below.

    If you have not already done so, you will need to create an account before you can register for this conference.

    For any questions regarding registration, please contact Esme Carruthers.

    For booking Terms and Conditions click here.

    Sponsors

    There are various sponsorship opportunities available at this conference, please contact Debbie Cockayne for further details.

    Top